Dr. Melissa Murphy, M.D.
What this data tells you about Dr. Murphy
Dr. Melissa Murphy is a pain medicine in Grapevine, TX, with 11 years in practice. Based on federal Medicare data, Dr. Murphy performed 2,035 Medicare services across 1,545 unique beneficiaries.
Between the years covered by Open Payments, Dr. Murphy received a total of $487,137 from 17 pharmaceutical and/or device companies across 1026 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Murphy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 381 | $87 | $203 |
| Office visit, established patient (20-29 min) | 335 | $65 | $152 |
| New patient office visit (30-44 min) | 136 | $78 | $197 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 104 | $220 | $1,558 |
| Injection of substance into lower spine canal using imaging guidance | 95 | $189 | $456 |
| New patient office visit (45-59 min) | 91 | $119 | $289 |
| X-ray of lower and sacral spine, 2-3 views | 82 | $29 | $131 |
| Injection, ketorolac tromethamine, per 15 mg | 82 | $0 | $2 |
| X-ray of pelvis, 1-2 views | 79 | $21 | $114 |
| Insertion of spinal neurostimulator electrode array through skin | 77 | $243 | $2,065 |
| Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | 71 | $89 | $400 |
| Injection of substance into middle or upper spine canal using imaging guidance | 56 | $76 | $750 |
| Injection of lower or sacral spine facet joint using imaging guidance, single level | 55 | $197 | $1,556 |
| Injection of lower or sacral spine facet joint using imaging guidance, second level | 53 | $107 | $486 |
| Drug injection, under skin or into muscle | 44 | $10 | $200 |
| X-ray of middle spine, 2 views | 33 | $23 | $139 |
| X-ray of upper spine, 2-3 views | 30 | $29 | $144 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 27 | $337 | $1,350 |
| Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | 26 | $196 | $400 |
| Office visit, established patient (10-19 min) | 23 | $41 | $96 |
| Injection of contrast for imaging of hip joint | 19 | $190 | $695 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $6 | $15 |
| Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | 18 | $152 | $1,073 |
| Insertion of spinal neurostimulator generator or receiver | 18 | $152 | $1,090 |
| Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | 16 | $360 | $713 |
| Remote patient monitoring management, 20 min/month | 16 | $34 | $87 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | 13 | $187 | $1,586 |
| Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | 13 | $65 | $512 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 12 | $9 | $75 |
| Joint injection, major joint | 11 | $63 | $318 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for pain medicine in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Murphy is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 1%).
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Murphy experienced with office visit, established patient (30-39 min)?
Does Dr. Murphy receive payments from pharmaceutical companies?
How do Dr. Murphy's costs compare to other pain medicines in Grapevine?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology